Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,500 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Jan 30, 2025
Webinar · 1:4:02
Dr. Clarissa Yates, CEO & Founder, Ketim Therapeutics